Detection of Carcinoma in Serous Effusions: a Review
Overview
Affiliations
A malignant serous effusion is one of the most common complications of advanced tumors, indicating a poor prognosis and having a profound impact on diagnosis, treatment, and prognosis. It is of great significance to identify benign and malignant effusions quickly and accurately. Both cellular and non-cellular components in the effusion can be employed for detection, diagnostic methods are necessary to obtain a definite diagnosis and more relevant information such as tumor classification. In this review, we focus on the comparison of several widespread cytological preparation methods, enrichment technology of exfoliated cells, and present tests for serous effusions, mainly including routine and special stains, immunocytochemistry, electron microscopy, enzyme-linked immunosorbent assay, flow cytometry, and molecular analysis.
Li B, Nong L, Zhang J, Wang W, Wang Q, Zhang Y Curr Oncol. 2022; 29(10):7637-7644.
PMID: 36290880 PMC: 9600574. DOI: 10.3390/curroncol29100603.
Diagnostic Value of Claudin-4 and EZH2 Immunohistochemistry in Effusion Cytology.
Elhosainy A, Hafez M, Yassin E, Adam M, Elnaggar M, Aboulhagag N Asian Pac J Cancer Prev. 2022; 23(8):2779-2785.
PMID: 36037134 PMC: 9741875. DOI: 10.31557/APJCP.2022.23.8.2779.
Takano G, Amorim R, Ferreira V, Vianna L, Castro T, Carneiro M Int J Clin Exp Pathol. 2022; 15(4):191-200.
PMID: 35535203 PMC: 9077109.
Xue J, Liu H, Meng G, Ding Z, Yan L, Yao S Cancer Immunol Immunother. 2021; 71(7):1633-1644.
PMID: 34750662 PMC: 10992106. DOI: 10.1007/s00262-021-03103-2.